Interesting write up from Dana Farbers Anthony D'Amico.jco.ascopubs.org/content/early/2011/04/04/JCO.2010.34.2006.full.pdf+html
The point is that yes there are more men that can choose active surveillance but the problem is that it is not easy to discern who they are. D'Amico writes that we needs better tools to make better recommendations. Low PSA and G6 alone is not a reliable tool...This article talks about
the use of stereotactic body radiation as a precaution...
Advanced Prostate Cancer at age 44 (I am 48 now)
pT3b,N0,Mx (original PSA was 19.8) EPE, PM, SVI. Gleason 4+3=7
Da Vinci Surgery ~ 2/16/2007
Adjuvant Radiation Therapy ~ IMRT Completed 8/07
Adjuvant Hormone Therapy ~ 28 months on Casodex and Lupron.